Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANRO
#2247
Alto Neuroscience, Inc. Common Stock
35.1
3
USD
-0.03%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-3.01%
Monthly Change
+32.52%
6 month change
+81.46%
Year Change
+854.62%
Previous Close
36.2
2
Open
35.2
8
Low
35.0
0
High
35.4
0
Volume
75
Markets
US Stock Market
Healthcare
Biotechnology
ANRO
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2024
2025
TTM
Cash from operating activities
-47.42 M
-51.77 M
-68.28 M
Cash from investing activities
-2.08 M
-24 K
-556 K
Cash from financing activities
135.69 M
60.08 M
165.01 M
Free cash flow
-47.42 M
-51.79 M
-68.84 M
News
Alto Neuroscience: Buy ALTO-207 Advancement TRD And Other Expansion Indications (ANRO)
Stocks Recover on Hopes Strait of Hormuz Could Soon Reopen
Stocks Pare Losses on Hormuz Report
Stocks Sink as President Trump Signals Iran War Will Drag On
Top 1% Alto Neuroscience Plummets On Its Shocking Schizophrenia Miss
Jefferies raises Alto Neuroscience stock price target on pipeline
Alto Neuroscience raises $120M to fund depression drug trial
Alto Neuroscience completes enrollment in schizophrenia drug trial
Alto Neuroscience receives patent for depression treatment method
Chardan Capital Markets assumes coverage on Alto Neuroscience stock with Buy rating
Tesla and ServiceNow among market cap stock movers on Monday
Alto Neuroscience: 4 Shots At Success In CNS Diseases In 2026 (NYSE:ANRO)